Granules India expects FDA nod for drug from Gagillapur facility by FY26 - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Granules India expects FDA nod for drug from Gagillapur facility by FY26

It had voluntarily paused production in September


Post Top Ad